Invenomic Institutional holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Invenomic Fund Institutional Class shares BIVIX
- NAV / 1-Day Return $20.02 / +4.76 %
- Fund Size $849.9M
- Adjusted Expense Ratio 2.240%
- Net Expense Ratio 3.040%
- Fee Level: Distribution High
- Share Class Type Institutional
- Morningstar Category Long-Short Equity
- Equity Style Box (Funds) Small Value
- Minimum Initial Investment $50,000
- Investment Status Limited
- TTM Yield 1.94%
- Turnover Ratio 197%
Morningstar’s Analysis BIVIX
Will BIVIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 28.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Us Dollar Broker | 69.77 | 608M | Cash and Equivalents |
First American Government Obligs X | 8.65 | 75M | Cash and Equivalents |
Workday Inc Class A | 3.32 | 29M | Technology |
Salesforce Inc | 3.05 | 27M | Technology |
Universal Health Services Inc Class B | 3.03 | 26M | Healthcare |
Global Payments Inc | 3.01 | 26M | Industrials |
Intuit Inc | 2.87 | 25M | Technology |
Fidelity National Information Services Inc | 2.81 | 25M | Technology |
Charter Communications Inc Class A | 2.75 | 24M | Communication Services |
Australian Dollar | 2.59 | 23M | Cash and Equivalents |